Adiumentum Capital Fund I LP 13D and 13G filings for Atara Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-05 4:07 pm Purchase |
2024-09-03 | 13D | Atara Biotherapeutics, Inc. ATRA |
Adiumentum Capital Fund I LP | 1,134,322 19.990% |
811,685 (+251.58%) |
Filing |
| 2024-05-22 6:18 pm Purchase |
2024-05-15 | 13D | Atara Biotherapeutics, Inc. ATRA |
Adiumentum Capital Fund I LP | 322,637 6.700% |
322,637 (New Position) |
Filing |